Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2018-03-29 | Cavan Redmond, 57, joined our Board of Directors during February 2018. ... Mr. Redmond is a seasoned healthcare strategist, who has held a number of global leadership positions. ... Mr. Redmond also serves as a director of OncoCyte Corporation. |
| 2019-06-14 | Cavan Redmond. Since 2014, Mr. Redmond has served as Partner for Zarsy, LLC. ... Mr. Redmond brings to our Board significant knowledge of the pharmaceuticals industry and extensive experience as an executive and board member of publicly traded companies. ... 2018 Director Compensation ... Cavan Redmond $60,625 Fees Earned or Paid in Cash, $94,006 Option Award, Total $154,631. |
Data sourced from SEC filings. Last updated: 2025-12-06